Immune checkpoint inhibitors in cancer treatment and potential effect modification by age.Acta Oncol. 2020 Mar; 59(3):247-248.AO
Links
MeSH
Pub Type(s)
Editorial
Language
eng
PubMed ID
32036733
Citation
Eriksson, Hanna, and Karin E. Smedby. "Immune Checkpoint Inhibitors in Cancer Treatment and Potential Effect Modification By Age." Acta Oncologica (Stockholm, Sweden), vol. 59, no. 3, 2020, pp. 247-248.
Eriksson H, Smedby KE. Immune checkpoint inhibitors in cancer treatment and potential effect modification by age. Acta Oncol. 2020;59(3):247-248.
Eriksson, H., & Smedby, K. E. (2020). Immune checkpoint inhibitors in cancer treatment and potential effect modification by age. Acta Oncologica (Stockholm, Sweden), 59(3), 247-248. https://doi.org/10.1080/0284186X.2020.1724329
Eriksson H, Smedby KE. Immune Checkpoint Inhibitors in Cancer Treatment and Potential Effect Modification By Age. Acta Oncol. 2020;59(3):247-248. PubMed PMID: 32036733.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Immune checkpoint inhibitors in cancer treatment and potential effect modification by age.
AU - Eriksson,Hanna,
AU - Smedby,Karin E,
Y1 - 2020/02/08/
PY - 2020/2/11/pubmed
PY - 2020/11/24/medline
PY - 2020/2/11/entrez
SP - 247
EP - 248
JF - Acta oncologica (Stockholm, Sweden)
JO - Acta Oncol
VL - 59
IS - 3
SN - 1651-226X
UR - https://www.unboundmedicine.com/medline/citation/32036733/Immune_checkpoint_inhibitors_in_cancer_treatment_and_potential_effect_modification_by_age_
DB - PRIME
DP - Unbound Medicine
ER -